论文部分内容阅读
目的 :探讨支气管哮喘患儿的临床病情分析,通过临床分析来提小儿支气管哮喘感染的诊疗水平。方法 :回顾性我院2012年6月—2013年6月收治的48例支气管哮喘患儿的临床资料,随机分为治疗组和观察组,治疗组接受西药和中药复方麻杏石甘汤联合治疗,观察组接受常规西药治疗。结果 :初诊时患儿支气管哮喘诱因均为呼吸道感染.患儿在采用西药加中药联合治疗后,病情均有所好转,哮喘得到有效控制,2例(4.3%)慢性感染患儿因停药而出现病情复发现象。结论 :支气管哮喘病患儿应采用西药和中药复方麻杏石甘汤联合治疗,且效果显著,可在临床上推广。
Objective: To investigate the clinical condition of children with bronchial asthma and to analyze the diagnosis and treatment of bronchial asthma in children through clinical analysis. Methods: The clinical data of 48 children with bronchial asthma admitted in our hospital from June 2012 to June 2013 were randomly divided into treatment group and observation group. The treatment group received Western medicine combined with Chinese medicine compound Maxingshigan Decoction The observation group received routine western medicine. Results: The predisposing factors of bronchial asthma were all respiratory tract infection in the newly diagnosed children.With western medicine and traditional Chinese medicine combined treatment, the condition was improved and the asthma was effectively controlled. Two children (4.3%) with chronic infection died of drug- Recurrence of the phenomenon. Conclusion: Children with bronchial asthma should be combined with western medicine and Chinese medicine compound Maxingshigan Decoction, and the effect is significant and can be popularized clinically.